Register  /  Login               
P. 41-46 /

China: the emerging market for clinical research

PharmaNet Development Group, Inc.
504 Carnegie Center
Princeton, NJ 08540, USA


The improved regulatory andeconomic environment,combined with rapid patient recruitment and a largepopulation’s growing need for healthcare treatment make acountry like China very attractive market for conductingclinical trials. Data on, one of the mostcomprehensive websites where researches register theirstudies, show that China has a cumulative total of 1725completed or ongoing trials by April 2010. With a robust clinicalresearch infrastructure and improved regulatory framework,China is a leading contributor to the annual growth rate ofclinical trials (1).


About us

tks | publisher, event organiser,
media agency

Viale Brianza, 22
20127 - Milano - Italy
Tel. +39 02 26809375